Translational drug development for women’s health
We are advancing women’s health by developing drug delivery solutions that address unique biological needs while remaining affordable, acceptable, and accessible. Our work focuses on translational platforms for contraception, STI prevention, and multipurpose prevention technologies. We advance platform technologies like vaginal films and implants into scalable, clinically viable products. Through DoE‑guided optimization, advanced manufacturing, pharmacokinetic studies, and predictive modeling, we are accelerating promising formulations toward IND and clinical translation.